Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study

Published:2018-06-05 Issue:2 Volume:48 Page:196-205
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bae J. M.¹,Lee H. H.²³^ORCID,Lee B.-I.²³^ORCID,Lee K.-M.²,Eun S. H.¹,Cho M.-L.⁴,Kim J. S.²³,Park J. M.²³,Cho Y.-S.²³,Lee I. S.²³,Kim S. W.²,Choi H.²,Choi M.-G.²³^ORCID

Affiliation:

1. Department of Dermatology; College of Medicine; The Catholic University of Korea; Seoul Korea

2. Division of Gastroenterology; Department of Internal Medicine; College of Medicine; The Catholic University of Korea; Seoul Korea

3. Catholic Photomedicine Research Institute; Seoul Korea

4. The Rheumatism Research Center; Catholic Research Institute of Medical Science; The Catholic University of Korea; Seoul Korea

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14822/fullpdf

Reference41 articles.

1. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease;Schreiber;Lancet,1999

2. The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy;Travis;J Crohns Colitis,2012

3. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase;Akazawa;J Gastroenterol,2002

4. Long-term outcome of patients with ulcerative colitis and primary non-response to infliximab;Papamichael;J Crohns Colitis,2016

5. Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease;Peyrin-Biroulet;Clin Gastroenterol Hepatol,2017

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study;Digestive and Liver Disease;2024-06

2. Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies;Psoriasis: Targets and Therapy;2023-09

3. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series;Infection and Drug Resistance;2023-08

4. A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based Study;Inflammatory Bowel Diseases;2023-06-02

5. Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study;Journal of Clinical Medicine;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3